Hot Pursuit     09-Jan-20
Alembic Pharma gains after JV firm clears USFDA inspection
Alembic Pharmaceuticals rose 2.46% to Rs 565.60 after the company announced successful completion of US drug regulator's inspection at Aleor Dermaceuticals.
Aleor Dermaceuticals (Aleor), a 60:40 joint venture between Alembic Pharmaceuticals (Alembic) and Orbicular Pharmaceutical Technologies (Orbicular), has completed United States Food and Drug Administration (USFDA) inspection at its formulation manufacturing facility located at Karakhadi, Gujarat without any observations. The inspection was carried out from 6 to 8 January 2020, Alembic Pharma said in a statement after market hours yesterday.

The Alembic Pharma stock trades above its 100 days simple moving average placed at 538.42 which will act as a crucial support in near term.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. Alembic has a cumulative total of 110 Abbreviated New Drug Application (ANDA) approvals (97 final approvals and 13 tentative approvals) from USFDA.

On a consolidated basis, the drug maker's net profit rose 23.1% to Rs 246.27 crore on a 10.1% rise in the net sales to Rs 1240.87 crore in Q2 September 2019 over Q2 September 2018.

Previous News
  Alembic Pharmaceuticals consolidated net profit rises 2.41% in the September 2023 quarter
 ( Results - Announcements 07-Nov-23   15:08 )
  Alembic Pharma gets USFDA nod for Icatibant injection
 ( Hot Pursuit - 17-Jun-24   14:03 )
  Volumes spurt at Blue Star Ltd counter
 ( Hot Pursuit - 20-Sep-23   14:30 )
  Alembic Pharmaceuticals receives USFDA approval for Betamethasone Valerate Foam
 ( Corporate News - 24-Aug-24   14:03 )
  Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
 ( Corporate News - 03-Oct-24   09:23 )
  Alembic Pharmaceuticals consolidated net profit declines 29.03% in the December 2022 quarter
 ( Results - Announcements 01-Feb-23   17:10 )
  Alembic Pharma gets USFDA nod for Betamethasone Valerate Foam
 ( Hot Pursuit - 24-Aug-24   16:59 )
  Alembic receives USFDA approval for Fesoterodine Fumarate ER Tablets
 ( Corporate News - 06-Jan-23   11:03 )
  Alembic Pharmaceuticals receives USFDA approval for Adapalene and Benzoyl Peroxide Topical Gel
 ( Corporate News - 08-Aug-22   11:04 )
  Alembic Pharmaceuticals receives USFDA approval for various products
 ( Corporate News - 09-May-24   09:01 )
  Alembic Pharmaceuticals announces board meeting date
 ( Corporate News - 19-Jan-24   14:13 )
Other Stories
  Transformers and Rectifiers gains on bagging order worth Rs 565-cr
  03-Oct-24   11:16
  Volumes jump at Just Dial Ltd counter
  03-Oct-24   11:00
  Hero MotoCorp total sales spurts 19% YoY in Sep
  03-Oct-24   10:50
  Yes Bank's loan book rises to Rs 2.36 lakh crore in Q2 FY25; deposits up over 18% YoY
  03-Oct-24   10:46
  Dabur India slides on forecasting mid-single digit revenue dip in Q2 FY25
  03-Oct-24   10:46
  KRN Heat Exchanger makes stellar debut
  03-Oct-24   10:31
  Maruti Suzuki total sales rises to 1,84,727 units in Sep’24
  03-Oct-24   10:12
  Metal shares gain
  03-Oct-24   10:00
  Basic materials shares gain
  03-Oct-24   10:00
  Telecom shares rise
  03-Oct-24   10:00
Back Top